Page 3 - Chris Schaber News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chris schaber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chris Schaber Today - Breaking & Trending Today

Ohio Northern University brings mobile clinic to Marion, sees low turnout


Ohio Northern University brings mobile clinic to Marion, sees low turnout
After delaying its first clinic earlier this month, Ohio Northern University s HealthWise Mobile Clinic made its debut in Marion Tuesday at the Marion County Fairgrounds. 
Healthwise resident Makayla Wells said 15 appointments were made for the clinic, with staff bringing 20 doses of the Moderna and Johnson & Johnson vaccines. Wells said turnout for the clinic was considerably lower than previous ones. 
We had a better turnout prior to the pause of the Johnson & Johnson vaccine, Wells said. At some of our other clinics we were doing 400 or 500 vaccines in a day, so pretty busy clinics. But now that we ve been doing this for almost a month, a lot of people who were eager to get their vaccine, they scheduled right away. ....

United States , Marion County , Chris Schaber , Patty Badertscher , Jim Henderson , Centers For Disease , Drug Administration , Ohio Northern University Healthwise Mobile Clinic , Ohio Northern University , Healthwise Mobile Clinic , Marion Tuesday , Makayla Wells , Washington Post , Disease Control , New Bloomington , ஒன்றுபட்டது மாநிலங்களில் , மரியன் கவுண்டி , கிறிஸ் ஸ்கேபர் , ஜிம் ஹென்டர்சன் , மையங்கள் க்கு நோய் , ஓஹியோ வடக்கு பல்கலைக்கழகம் , மரியன் செவ்வாய் , மாகயில கிணறுகள் , வாஷிங்டன் போஸ்ட் , நோய் கட்டுப்பாடு , புதியது பூக்கும் ,

PCG Digital: Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301


(3)
New York, New York (Newsfile Corp. - February 9, 2021) - PCG Digital: Soligenix (NASDAQ: SNGX) continues to build excitement for its SGX301 candidate following strong Phase 3 data and commercialization plans. The company recently held an investor webcast to further explain the company s plans for commercializing its ground-breaking SGX301 candidate for the treatment of cutaneous T-cell lymphoma (CTCL).
Here are some key takeaways from the commercialization Q&A:
1. Soligenix will commercialize SGX301 in the U.S. on its own
During the presentation, the company noted that after conducting necessary due diligence and simulating different routes to commercialization, it was determined that a partnership would not be the best solution for shareholders. The licensing landscape and CTCL s small, orphan market were the key drivers behind the decision. Considering that the average biopharmaceutical licensing deal, a Phase 3 licensor will typically retain no more than 40 ....

New York , United States , Chris Schaber , Jonathan Guarino , Zack Research Updates Soligenix , York Newsfile Corp , Cap Research , Advisory Inc , Digital Holdings , Multiple Near Term Catalysts Anticipated , New Drug Application , Clinical Study Report , Prescription Drug User Fee Act , American Academy , Dermatology Meeting , Investigative Dermatology Meeting , Research Updates Soligenix , Positive Report , Small Cap Research , Paid Advertising , Securities Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸ் ஸ்கேபர் , ஜொனாதன் குவாரினோ , தொப்பி ஆராய்ச்சி ,